Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584363 · ClinicalTrials.gov registry record
Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 731
- Enrollment target
NCT00584363: Completed study, sponsored by University of Alabama at Birmingham.
NCT00584363 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 731 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00584363 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 731 participants
- Enrollment target
Study Summary
The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 731 participants |
| Start Date | 2004-06 |
| Est. Completion | 2017-09 |
What the finished NCT00584363 record still lists
NCT00584363 is an observational study that tracks outcomes without assigning an intervention. The registered 731 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00584363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00584363 about?
NCT00584363 is a clinical study titled "Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection". The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.
What is the current status of trial NCT00584363?
This trial is currently completed. The enrollment target is 731 participants. The study started on 2004-06. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT00584363?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- NCT07312162 · 730 participants
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia